Seattle, Washington, United States Accelerator Corp. appeared to be the VC, which was created in 2003. The venture was found in North America in United States. The leading representative office of defined VC is situated in the Seattle.
The common things for fund are deals in the range of 1 - 5 millions dollars. The important activity for fund was in 2016. This Accelerator Corp. works on 4 percentage points less the average amount of lead investments comparing to the other organizations. The top amount of exits for fund were in 2013. The fund is constantly included in less than 2 investment rounds annually. Considering the real fund results, this VC is 30 percentage points more often commits exit comparing to other organizations.
Besides them, we counted 7 critical employees of this fund in our database.
The fund has specific favorite in a number of founders of portfolio startups. Besides, a startup needs to be aged 6-10 years to get the investment from the fund. For fund there is a match between the location of its establishment and the land of its numerous investments - United States. Among the most popular portfolio startups of the fund, we may highlight Oncofactor Corporation, Rodeo Therapeutics, ApoGen Biotechnologies. Among the most popular fund investment industries, there are Pharmaceutical, Biotechnology.
The standard case for the fund is to invest in rounds with 6-7 partakers. Despite the Accelerator Corp., startups are often financed by OVP Venture Partners, DFJ, Clarus Ventures. The meaningful sponsors for the fund in investment in the same round are Washington Research Foundation., ARCH Venture Partners, WuXi AppTec. In the next rounds fund is usually obtained by M Ventures, CRG L.P..
Related Funds
Funds with similar focus
| Fund Name | Location |
| Alfred P. Sloan Foundation | New York, New York, United States |
| Bigfoot Capital | Colorado, Denver, United States |
| British Columbia Discovery Fund | British Columbia, Canada, Vancouver |
| Cambridge Information Systems | Cambridge, Massachusetts, United States |
| CION Investments | Braintree, Massachusetts, United States |
| Debut Capital | - |
| Filter14 | California, San Francisco, United States |
| Fuzhou Jinkong Jijin Guanli Co., Ltd | China, Fuzhou, Jiangxi |
| Gakken Holdings Japan | Chiyoda, Japan |
| Government of Saskatchewan | - |
| Growth and Transition Capital | - |
| Health Catalyst | Salt Lake City, United States, Utah |
| Mid-America Angels | Kansas, Overland Park, United States |
| Morinaga | Japan, Tokyo |
| Novo Networks | - |
| Salta Capital | Australia, Melbourne, Victoria |
| Shanghai Housing and Urban-Rural Development Creative Enterprise Management | China, Shanghai, Xuhui |
| Value Invest Korea (VIK) | Seoul, Seoul-t'ukpyolsi, South Korea |
| Zhejiang Huamei Holding | China, Hangzhou, Zhejiang |
Discover 5 more decision makers Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Rodeo Therapeutics | $5M | 25 Jul 2017 | Seattle, Washington, United States | ||
ApoGen Biotechnologies | $7M | 12 Dec 2016 | Seattle, Washington, United States | ||
Oncofactor | $2M | 02 Aug 2011 | Seattle, Washington, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Rodeo Therapeutics | $5M | 25 Jul 2017 | Seattle, Washington, United States | ||
ApoGen Biotechnologies | $7M | 12 Dec 2016 | Seattle, Washington, United States | ||
Oncofactor | $2M | 02 Aug 2011 | Seattle, Washington, United States |
